ArticleClinical rheumatology2014

The impact of conventional DMARD and biological therapies on CD4+ cell subsets in rheumatoid arthritis: a follow-up study.

Balázs Szalay et al.PubMed ↗Publisher ↗

No numbers read from the abstract.